Beruflich Dokumente
Kultur Dokumente
FY 2008 and FY 2009 net sales and gross margin outlook broadly unchanged
ADR BUY Fundamental research indicates a 63% upside in the ADR over the next 6-12 months. We have
Direct
calculatedaccess toprice
the target thebased
full on
report free of
fundamental charge
factors, using at
a weighted average of target prices
http://www.iirgroup.com/researchoracle/viewreport/show/20294
obtained using DCF and comparative valuation methodologies. We have taken a 6-12 month
investment horizon for this stock, as the semiconductor industry in which the company operates is
Ticker: OIIM highly cyclical and therefore trends can be captured more accurately with a shorter investment
Target price: US$9.43 horizon.
Current price: US$5.79 We reiterate the ADR a BUY with a 6-12 month target price of US$9.43 per ADR.
Hong Kong BUY The Hong Kong stock is expected to appreciate 44% over the next 6-12 months as the 63%
fundamental upside is offset by the anticipated reduction in the Hong Kong stock premium2 over the
Stock1 same period. The currency impact on the Hong Kong stock is assumed to be neutral since the Hong
Ticker: 0457.HK Kong dollar is pegged to the US dollar.
Target price: HK$1.58
Current price: HK$1.10 We reiterate the Hong Kong stock (1 ADR = 50 common shares) a BUY with a 6-12 month target price
of HK$1.58 per share.
Report summary
O2Micro International Limited’s (O2Micro) 1Q 08 net sales increased 7.2% y-o-y and gross margin
increased 392 bps y-o-y, driven by increased efficiency in product design and a favorable product mix,
in line with our expectations, However, adjusted non-US GAAP operating and net margin3 were
marginally below our estimates. Going forward, we expect O2Micro to continue to benefit from the
ongoing market transition from Cathode Ray Tube (CRT) to Liquid Crystal Diode (LCD) based displays.
Moreover, growing demand for mini-notebooks, steady demand for LCD-TVs and notebooks and
increasing acceptance of the company’s products are expected to augment net sales growth and limit
the impact of overall industry weakness. Furthermore, Management’s cost reduction initiatives are
expected to support margin expansion. Subsequently, our net sales and gross margin outlooks for the
company in FY 2008 and FY 2009 remain broadly unchanged but we have revised downwards our
adjusted non-US GAAP operating margin3 estimates to reflect a higher than previously anticipated
increase in Research & Development (R&D) expenses. We maintain our optimistic outlook for the
company based on the factors outlined above. Given the recent decline in the ADR price, the stock
offers an attractive investment opportunity at current levels.